Aobo Cerebral Rehabilitation Therapy Instrument, the first brain rehabilitation therapy instrument designed specifically for cerebral disease patients, scientifically rigorous mechanism, a new therapeutic approach, solving the problem that drugs can't solve, and in the treatment of cerebrovascular diseases with a qualitative leap and substantial breakthroughs. Its success lies in:
●Able to activate the brain cells in the inhibited state in a short time and make them participate in the work instead of those lost or dead brain cells, so that the damaged nervous system and functions can be restored.
●Can break the static and non-porous state of the blood-brain barrier and increase its permeability, which is conducive to the brain-healthy ions activating brain cells to cross the barrier and enter the nervous system freely.
●Able to tear and squeeze the embolus that has been mechanized, and reopen the occluded blood vessels.
The Aobo Cerebral Rehabilitation Therapeutic Instrument has won three national patents, passed extensive clinical verification by authoritative medical units and product quality testing by the Heilongjiang Provincial Bureau of Technical Supervision, and is a genuine "quasi" therapeutic instrument approved by the State Pharmaceutical Administration. In May 2005, it won the special prize of the 96th Paris International Invention Expo and was listed as a national torch plan project by the Ministry of Science and Technology.
Using Aobo Cerebral Rehabilitation Therapy Instrument, the effect will start in 15 days, and the improvement will be obvious in 3 months: the stroke patients who have been paralyzed in bed for many years will be able to walk on the ground, the delirious patients will regain their consciousness, the patients who have lost their hearing will be able to hear the sound, and the ones who have visual obstacles will be able to see the things, and the patients who have aphasia will be able to speak. It has successfully cured hundreds of thousands of patients with encephalopathy and benefited millions of people.